• Home
  • News
2021-08-10 | views:853
한미약품, mRNA 코로나 백신 개발에 나서… “개발되면 모더나보다 경쟁력 있어”
2021-08-10 | views:1267
MHRA approval for Phase 1 trial of lead cancer vaccine OVM-200
2021-08-09 | views:3744
테라젠바이오, '시그니처 유전자' 활용 맞춤형 항암제 선별 기술 특허
2021-08-05 | views:1603
S.Korea pledges nearly $2 bln to become major COVID-19 vaccine producer
2021-08-05 | views:1288
진단•의료기기 분야 3354억 유입…디지털 치료제 '주목'
2021-08-02 | views:999
디지털헬스산업, 코로나19로 급부상…규제개선 필수'
2021-07-28 | views:939
디지털치료제, 비만•당뇨로 범위 확장…
2021-07-23 | views:1186
한미약품그룹-레고켐바이오, 이중항체 ADC 항암신약 공동개발
2021-07-14 | views:1201
‘디지털 치료제’ 시장 급성장 전망...펀드 시장도 움직인다
  1.   
  2. 39
  3. 40
  4. 41
  5. 42
  6. 43
  7. 44
  8. 45
  • 10F, 173, Digital-ro, Geumcheon-gu, Seoul (Gasan-dong, Elysian)
  • Tel : 02-890-8700
  • IR Service : 02-6964-8770
  • Fax : 02-6964-8755

About Us

Goals & Promise

Leadership

Company History

IR

Notice & IR

Disclosure Information

Dx&Vx 2023 Award Impact

Contact

Private Policy Terms of Use twitter icon @dxvx_official
© 2024 Dx&Vx. All Rights Reserved.